PxRadia's Unattributed Round

PxRadia raised a round of funding on April 04, 2014.

PxRadia was formed in 2010 by Dr. Charles Morgan, a founder of multiple companies and a pioneer in monoclonal antibody development, with an exclusive license from Memorial Sloan-Kettering Cancer Cente…

Articles about PxRadia's Unattributed Round: